Original InvestigationImpact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. AlBadri is supported by Ruth L. Kirschstein Institutional National Research Service Award Training Grant T32HL007745. This work was also supported by the National Heart, Lung, and Blood Institute contracts N01-HV-68161, N01-HV-68162, N01-HV-68163, and N01-HV-68164, grants U0164829, U01 HL649141, U01 HL649241, K23HL105787, T32HL69751, R01 HL090957, and 1R03AG032631 from the National Institute on Aging, GCRC grant M01-RR00425 from the National Center for Research Resources, the National Center for Advancing Translational Sciences grants UL1TR000124 and UL1TR001427, and grants from the Gustavus and Louis Pfeiffer Research Foundation, Danville, New Jersey, The Women’s Guild of Cedars-Sinai Medical Center, Los Angeles, California, The Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, Pennsylvania, and QMED, Inc., Laurence Harbor, New Jersey, the Edythe L. Broad and the Constance Austin Women’s Heart Research Fellowships, Cedars-Sinai Medical Center, Los Angeles, California, the Barbra Streisand Women’s Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles, The Society for Women’s Health Research (SWHR), Washington, DC, The Linda Joy Pollin Women’s Heart Health Program, and the Erika Glazer Women’s Heart Health Project, Cedars-Sinai Medical Center, Los Angeles, California. This work is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or National Institutes of Health. Dr. Bairey Merz has been a speaker for Abbott Diagnostics and served on the board of directors for iRhythm. Dr. Bittner has received institutional contracts to serve as a steering committee member for Sanofi; as a national trial coordinator for AstraZeneca, DalCor, and Esperion; as a trial coinvestigator for Amgen; and as a site principal investigator for AstraZeneca and Bayer; and has served on advisory boards for Sanofi. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Listen to this manuscript's audio summary by Editor-in-Chief Dr. Valentin Fuster on JACC.org.